Teva

CINQAIR

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / CINQAIR – J2786

Manufacturer:

Teva

Name:

CINQAIR

HCPCS Code Descriptor:

Injection, reslizumab, 1 mg

Category:

J Code

HCPCS:

J2786

NDC(s):

59310-0610-31

Primary Type:

Anti-Eosinophil Asthma

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

CINQAIR is an Anti-Eosinophil Asthma drug manufactured by Teva and administered via the Intravenous route of administration. The J Code: J2786 is aligned to the drug CINQAIR.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/17

HCPCS Effective Date:

1/1/17

HCPCS Short Description:

Injection, reslizumab, 1mg

Billing and Coding Guide:

https://www.tevasupportsolutions.com/globalassets/tss-hcp/pdfs/at-a-glance-guide-to-codes-cinqair.pdf

Patient Assistance:

https://www.tevasupportsolutions.com/patients/